Vigil Neuroscience, Inc. (VIGL)
USD 1.65
(-4.62%)
USD 1.65
(-4.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | - | - | - | - |
| Cost of Revenue | 399 Thousand | 1.01 Million | 345 Thousand | - |
| Gross Profit | -399 Thousand | -1.01 Million | -345 Thousand | - |
| Operating Expenses | 88.86 Million | 68.88 Million | 42.4 Million | 6.29 Million |
| Selling, General and Administrative Expenses | 27.93 Million | 21.44 Million | 10.07 Million | 1.77 Million |
| Research and Development Expenses | 60.93 Million | 47.44 Million | 32.33 Million | 4.51 Million |
| Other Expenses | - | -44 Thousand | -877 Thousand | - |
| Cost and Expenses | 88.86 Million | 68.88 Million | 42.4 Million | 6.29 Million |
| Operating Income | -88.86 Million | -68.88 Million | -42.4 Million | -6.29 Million |
| Interest Expense | - | - | - | - |
| Income Tax Expense | - | -579 Thousand | -31 Thousand | -12.58 Thousand |
| Earnings before Tax | -82.63 Million | -68.3 Million | -43.28 Million | -28.54 Million |
| Net Income | -82.63 Million | -67.72 Million | -43.25 Million | -28.54 Million |
| Earnings Per Share Basic | -2.13 | -2.14 | -28.24 | -1.01 |
| Earnings Per Share Diluted | -2.13 | -2.14 | -28.24 | -1.01 |
| Weighted Average Shares Outstanding | 38.71 Million | 31.68 Million | 1.53 Million | 28.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.71 Million | 31.68 Million | 1.53 Million | 28.26 Million |
| Gross Margin | - | - | - | - |
| EBIT Margin | - | - | - | - |
| Profit Margin | - | - | - | - |
| EBITDA | -88.46 Million | -67.29 Million | -42.93 Million | -28.54 Million |
| Earnings Before Tax Margin | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1.93 Million | - | - | - |
| Cost of Revenue | 113 Thousand | 113 Thousand | 113 Thousand | 399 Thousand | 110 Thousand | 474 Thousand |
| Gross Profit | -113 Thousand | -113 Thousand | 1.82 Million | -399 Thousand | -110 Thousand | -474 Thousand |
| Operating Expenses | 22.36 Million | 21.3 Million | 23.74 Million | 88.46 Million | 22.32 Million | 21.91 Million |
| Selling, General and Administrative Expenses | 6.82 Million | 6.97 Million | 6.96 Million | - | 6.9 Million | 7.01 Million |
| Research and Development Expenses | 15.54 Million | 14.32 Million | 16.78 Million | - | 15.41 Million | 14.9 Million |
| Other Expenses | -3000.00 | -2000.00 | 2000.00 | - | -3000.00 | -7000.00 |
| Cost and Expenses | 22.47 Million | 21.41 Million | 23.85 Million | 88.86 Million | 22.32 Million | 21.91 Million |
| Operating Income | -22.47 Million | -21.41 Million | -23.85 Million | -88.86 Million | -22.32 Million | -21.91 Million |
| Interest Expense | - | - | 1.04 Million | - | - | - |
| Income Tax Expense | - | 69.72 Thousand | 2.9 Million | - | -110 Thousand | -1.74 Million |
| Earnings before Tax | -21.22 Million | -19.94 Million | -22.17 Million | -82.63 Million | -20.49 Million | -20.17 Million |
| Net Income | -21.22 Million | -19.94 Million | -22.17 Million | -82.63 Million | -20.49 Million | -20.17 Million |
| Earnings Per Share Basic | -0.52 | -0.50 | -0.57 | - | -0.53 | -0.52 |
| Earnings Per Share Diluted | -0.52 | -0.50 | -0.57 | - | -0.53 | -0.52 |
| Weighted Average Shares Outstanding | 40.56 Million | 39.86 Million | 38.83 Million | 38.71 Million | 38.8 Million | 38.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 40.56 Million | 39.86 Million | 38.83 Million | 38.71 Million | 38.8 Million | 38.65 Million |
| Gross Margin | - | - | 0.94 | - | - | - |
| EBIT Margin | - | - | -12.28 | - | - | - |
| Profit Margin | - | - | -11.47 | - | - | - |
| EBITDA | -22.36 Million | -21.3 Million | -23.74 Million | - | -22.32 Million | -21.8 Million |
| Earnings Before Tax Margin | - | - | -12.34 | - | - | - |
300820
4113
GWSAF
DAY
8012
EQR